ATE206138T1 - Helicobacter pylori antigen - Google Patents

Helicobacter pylori antigen

Info

Publication number
ATE206138T1
ATE206138T1 AT96902390T AT96902390T ATE206138T1 AT E206138 T1 ATE206138 T1 AT E206138T1 AT 96902390 T AT96902390 T AT 96902390T AT 96902390 T AT96902390 T AT 96902390T AT E206138 T1 ATE206138 T1 AT E206138T1
Authority
AT
Austria
Prior art keywords
helicobacter pylori
antigen
pylori antigen
novel
antigenic fragments
Prior art date
Application number
AT96902390T
Other languages
English (en)
Inventor
Christopher John Smith
Robert Clancy
Allan Cripps
Original Assignee
Provalis Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provalis Uk Ltd filed Critical Provalis Uk Ltd
Application granted granted Critical
Publication of ATE206138T1 publication Critical patent/ATE206138T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K2039/106Vibrio; Campylobacter; Not used, see subgroups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96902390T 1995-02-15 1996-02-15 Helicobacter pylori antigen ATE206138T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9502899.9A GB9502899D0 (en) 1995-02-15 1995-02-15 Novel antigen
PCT/GB1996/000351 WO1996025430A1 (en) 1995-02-15 1996-02-15 Helicobacter pylori antigen

Publications (1)

Publication Number Publication Date
ATE206138T1 true ATE206138T1 (de) 2001-10-15

Family

ID=10769595

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96902390T ATE206138T1 (de) 1995-02-15 1996-02-15 Helicobacter pylori antigen

Country Status (18)

Country Link
EP (1) EP0809653B1 (de)
JP (1) JPH11503999A (de)
KR (1) KR19980701698A (de)
CN (1) CN1175955A (de)
AT (1) ATE206138T1 (de)
AU (1) AU714222B2 (de)
CA (1) CA2212952A1 (de)
DE (1) DE69615537T2 (de)
DK (1) DK0809653T3 (de)
ES (1) ES2164231T3 (de)
FI (1) FI973335A (de)
GB (1) GB9502899D0 (de)
IL (1) IL117151A (de)
NO (1) NO973753D0 (de)
NZ (1) NZ301334A (de)
PT (1) PT809653E (de)
WO (1) WO1996025430A1 (de)
ZA (1) ZA9601216D (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599509B2 (en) 1997-09-02 2003-07-29 Massachusetts Institute Of Technology Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease
CN1105185C (zh) * 1998-11-30 2003-04-09 上海晶莹生物技术有限公司 基因表达幽门螺杆菌细胞毒素相关基因a蛋白抗原制备工艺
AUPQ854100A0 (en) * 2000-07-03 2000-07-27 Helirad Pty Ltd Methods for monitoring treatment of helicobacter infection
SE0101030D0 (sv) * 2001-03-23 2001-03-23 Nordic Bio Ab Immunogenic cell surface proteins of helicobacter pylori

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
DE4139840B4 (de) * 1990-12-04 2005-06-02 Quidel Corp., San Diego Antigen-Zubereitung zum Nachweis von H. pylori
JPH07509308A (ja) * 1992-04-29 1995-10-12 オースファーム インターナショナル リミテッド ヘリコバクターピロリのinvitro試験

Also Published As

Publication number Publication date
ES2164231T3 (es) 2002-02-16
IL117151A0 (en) 1996-06-18
MX9706267A (es) 1997-11-29
NO973753L (no) 1997-08-14
EP0809653B1 (de) 2001-09-26
IL117151A (en) 2001-06-14
FI973335A0 (fi) 1997-08-14
NO973753D0 (no) 1997-08-14
ZA9601216D (en) 1997-09-15
AU714222B2 (en) 1999-12-23
DE69615537T2 (de) 2002-04-18
KR19980701698A (ko) 1998-06-25
AU4672896A (en) 1996-09-04
FI973335A (fi) 1997-08-14
PT809653E (pt) 2002-03-28
NZ301334A (en) 1999-08-30
GB9502899D0 (en) 1995-04-05
CN1175955A (zh) 1998-03-11
JPH11503999A (ja) 1999-04-06
WO1996025430A1 (en) 1996-08-22
DE69615537D1 (en) 2001-10-31
DK0809653T3 (da) 2001-11-19
EP0809653A1 (de) 1997-12-03
CA2212952A1 (en) 1996-08-22

Similar Documents

Publication Publication Date Title
NO963508L (no) Urease-basert vaksine og behandling av Helicobacter-infeksjon
WO1995020660A3 (en) Immunization by inoculation of dna transcription unit
ATE231002T1 (de) Menschliche, neutralisierende, monoklonale antikörper gegen das respiratorische synzytialvirus
GB2303855B (en) Helicobacter pylori antigenic protein preparation and immunoassays
EP1180938A4 (de) Agentien, zusammensetzungen und verfahren zur diagnose und/oder behandlung oder vorbeugung von plaquebildenden erkrankungen
DK1049488T3 (da) Fremgangsmåde og præparat til immunisering med Pseudomonas aeruginosa-V-antigenet
HK1005541A1 (en) Treatment of helicobacter associated gastroduodenal disease
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
DE69527986D1 (de) Antigene arznei zur behandlung oder vorbeugung
DK0954529T3 (da) Porphyromonas gingivalis-antigener til diagnose og behandling af rodbetændelse
NO954318D0 (no) Immunogent preparat av OspC-antigenvaksiner for forhindring og behandling av Lymesykdom, samt rekombinante fremgangsmåter for fremstilling av slike antigener
WO2002054073A3 (en) Latent human tuberculosis model, diagnostic antigens, and methods of use
ATE206138T1 (de) Helicobacter pylori antigen
PT946874E (pt) Diagnostico de helicobacter pylori
DE244295T1 (de) Aus weichtieren isoliertes immunogen, verfahren zur herstellung desselben, diagnostische reagenzien fuer menschliche bilharziosen, impfstoffe gegen schistosomiasis und immunisierende zubereitungen, die dieses immunogen enthalten.
CO5241277A1 (es) Vacuna
ATE204761T1 (de) Pharmazeutische antigen-/antikörperpräparation
MX9700215A (es) Proteinas y vacunas de helicobacter.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee